This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Pseudofolliculitis barbae

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Pseudofolliculitis describes folliculitis caused by ingrowing hairs in the beard area and on the back of the neck. This condition results in small papules on the areas of skin described (1).

This condition is worse in people with naturally curly hair and Afro-Caribbeans (1).

Scarring commonly occurs associated with this condition (1).

  • pseudofolliculitis barbae (also known colloquially as 'ingrown hairs' or 'razor bumps') is a common chronic inflammatory disorder occurring most often in regions of thick hair growth after shaving (2)
    • pathogenesis involves creating a sharp tip by shaving the distal end of the hair that enables intrafollicular and transfollicular penetration of thick hairs into the dermis
      • as the hairs grow, they coil back into the dermis, causing an inflammatory reaction
        • characterized clinically by multiple painful, pruritic erythematous papules and, less commonly, pustules, nodules, or abscesses; hyperpigmentation, hypertrophic scars and keloids can also occur

Reference:

  • 1) GP magazine (14/9/01), 38.
  • 2) Bolognia JL, Jorizzo JL, Schaffer JV. Dermatology. 3rd ed. New York: Saunders; 2012.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.